 SAN DIEGO, July 7, 2021 PRNewswire -- Johnson Fistel, LLP is investigating potential claims on behalf of ChemoCentryx Inc. ChemoCentryx or the Company NASDAQ: CCXI against certain of its current and former officers and directors. Recently a class action lawsuit was filed in federal court against the Company on behalf of purchasers of the securities of ChemoCentryx from November 26, 2019 and May 6, 2021 the Class Period. 